Hiroshi Watanabe
About
In The Last Decade
Hiroshi Watanabe
261 papers receiving 4.2k citations
Peers
Comparison fields: 5 of 140
- Cardiology and Cardiovascular Medicine 1.2k
- Surgery 1.1k
- Pulmonary and Respiratory Medicine 928
- Molecular Biology 875
- Rheumatology 626
Countries citing papers authored by Hiroshi Watanabe
This map shows the geographic impact of Hiroshi Watanabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Watanabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Watanabe more than expected).
Fields of papers citing papers by Hiroshi Watanabe
This network shows the impact of papers produced by Hiroshi Watanabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Watanabe. The network helps show where Hiroshi Watanabe may publish in the future.
Co-authorship network of co-authors of Hiroshi Watanabe
This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Watanabe. A scholar is included among the top collaborators of Hiroshi Watanabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Watanabe. Hiroshi Watanabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 10 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 4 | |
| 6 | Rapid Automated Genotyping of CYP2C19 and Helicobacter pylori 23S rRNA Gene in Gastric Juice | 12 |
| 7 | 1 | |
| 8 | 182 | |
| 9 | 46 | |
| 10 | 2 | |
| 11 | 2 | |
| 12 | OJ-429 Antiarrhythmic effects of magnesium sulfate for ventricular tachyarrhythmia developed under the condition of QT interval prolongation(ECG/Body Surface Potential Mapping/Holter 6 (A) : OJ52)(Oral Presentation (Japanese)) | 0 |
| 13 | 2 | |
| 14 | 0 | |
| 15 | Foreign Direct Investment in Central and East European Countries | 1 |
| 16 | [Elevation of cerebral lactate detected by localized 1H magnetic resonance spectroscopy in a patient with migraine]. | 3 |
| 17 | 1 | |
| 18 | 5 | |
| 19 | 3 | |
| 20 | [Studies on the fibrinolytic system in ruptured intracranial aneurysm.--Part 2: Fibrinogen changes in acute stage of SAH as a risk factor of the ischemic complications following vasospasm (author's transl)]. | 4 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.